Geoff Meacham
Stock Analyst at Citi
(4.82)
# 457
Out of 4,575 analysts
1188
Total ratings
59.1%
Success rate
14.1%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Maintained: Hold | $230 → $260 | $259.36 | +0.25% | 66 | Jul 16, 2026 | |
| FTH Faeth Therapeutics | Maintained: Buy | $55 | $28.29 | +94.41% | 3 | Jul 16, 2026 | |
| MANE Veradermics | Maintained: Buy | $135 → $160 | $109.51 | +46.11% | 8 | Jul 16, 2026 | |
| AMGN Amgen | Maintained: Hold | $345 | $376.04 | -8.25% | 44 | Jul 15, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $66 | $62.09 | +6.30% | 71 | Jul 15, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,500 → $1,600 | $1,196.03 | +33.78% | 99 | Jul 15, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $165 | $129.31 | +27.60% | 80 | Jul 15, 2026 | |
| MRK Merck & Co. | Maintained: Hold | $125 | $131.07 | -4.63% | 64 | Jul 15, 2026 | |
| PFE Pfizer | Maintained: Hold | $27 | $24.54 | +10.02% | 74 | Jul 15, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $700 | $656.01 | +6.71% | 59 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $585 | $477.36 | +22.55% | 66 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 | $58.83 | +12.19% | 26 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $200 | $202.19 | -1.08% | 71 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $41 | $54.07 | -24.17% | 60 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $110.57 | +8.53% | 18 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $135 | $134.28 | +0.54% | 16 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $136.11 | -4.49% | 11 | May 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 | $7.46 | -6.17% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 | $76.82 | -2.37% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $47.67 | +21.67% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $18.41 | +8.64% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $60 | $62.84 | -4.52% | 17 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $130 | $89.33 | +45.53% | 15 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $19.26 | +159.61% | 2 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $29.64 | +85.56% | 4 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.13 | +87.79% | 10 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $170 | $263.40 | n/a | 33 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $1.49 | n/a | 3 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $59.33 | n/a | 35 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $1.57 | n/a | 8 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $46.54 | n/a | 8 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $3.18 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $9 | $12.63 | n/a | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $26.71 | n/a | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $54.66 | n/a | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8509 | n/a | 4 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $15 | $30.63 | n/a | 4 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $51.35 | n/a | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.11 | n/a | 4 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $14 | $8.69 | n/a | 4 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $25 | $15.33 | n/a | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $86.22 | n/a | 1 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $18 | $84.02 | n/a | 6 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $28.42 | n/a | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 → $2 | $5.48 | n/a | 3 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 → $150 | $528.47 | n/a | 15 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $16 | $2.60 | n/a | 2 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $49 | $80.74 | n/a | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $24 | $0.9701 | n/a | 6 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $44 | $0.8475 | n/a | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $4 | $9.79 | n/a | 5 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $62 | $1.24 | n/a | 3 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $20 | $19.11 | n/a | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $9.73 | n/a | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $49 → $75 | $8.75 | n/a | 10 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $0.82 | n/a | 1 | Jun 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $31.54 | n/a | 1 | Mar 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $3.19 | n/a | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $9.34 | n/a | 1 | Dec 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $28.82 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.065 | n/a | 1 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $15.15 | n/a | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $57.36 | n/a | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €79.11 | €139.15 | n/a | 1 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 → $32 | $0.136 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $82 | $117.67 | n/a | 15 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $13 | $3.71 | n/a | 9 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $13.63 | n/a | 3 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $1.48 | n/a | 2 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $103 → $110 | $175.77 | n/a | 11 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $3.24 | n/a | 1 | Mar 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $43.71 | $6.25 | n/a | 6 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $105 | $271.77 | n/a | 8 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $20 → $8 | $22.86 | n/a | 2 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $25 → $16 | $12.78 | n/a | 2 | Oct 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $60 → $90 | $36.36 | n/a | 5 | Dec 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.93 | n/a | 1 | Sep 17, 2012 |
AbbVie
Jul 16, 2026
Maintained: Hold
Price Target: $230 → $260
Current: $259.36
Upside: +0.25%
Faeth Therapeutics
Jul 16, 2026
Maintained: Buy
Price Target: $55
Current: $28.29
Upside: +94.41%
Veradermics
Jul 16, 2026
Maintained: Buy
Price Target: $135 → $160
Current: $109.51
Upside: +46.11%
Amgen
Jul 15, 2026
Maintained: Hold
Price Target: $345
Current: $376.04
Upside: -8.25%
Bristol-Myers Squibb Company
Jul 15, 2026
Maintained: Hold
Price Target: $66
Current: $62.09
Upside: +6.30%
Eli Lilly and Company
Jul 15, 2026
Maintained: Buy
Price Target: $1,500 → $1,600
Current: $1,196.03
Upside: +33.78%
Gilead Sciences
Jul 15, 2026
Maintained: Buy
Price Target: $165
Current: $129.31
Upside: +27.60%
Merck & Co.
Jul 15, 2026
Maintained: Hold
Price Target: $125
Current: $131.07
Upside: -4.63%
Pfizer
Jul 15, 2026
Maintained: Hold
Price Target: $27
Current: $24.54
Upside: +10.02%
Regeneron Pharmaceuticals
Jul 15, 2026
Maintained: Hold
Price Target: $700
Current: $656.01
Upside: +6.71%
Jul 15, 2026
Maintained: Buy
Price Target: $585
Current: $477.36
Upside: +22.55%
Jul 15, 2026
Maintained: Buy
Price Target: $66
Current: $58.83
Upside: +12.19%
Jul 13, 2026
Maintained: Hold
Price Target: $200
Current: $202.19
Upside: -1.08%
Jun 26, 2026
Maintained: Hold
Price Target: $41
Current: $54.07
Upside: -24.17%
Jun 25, 2026
Maintained: Buy
Price Target: $120
Current: $110.57
Upside: +8.53%
Jun 23, 2026
Downgraded: Hold
Price Target: $125 → $135
Current: $134.28
Upside: +0.54%
May 10, 2026
Maintained: Buy
Price Target: $130
Current: $136.11
Upside: -4.49%
May 7, 2026
Maintained: Sell
Price Target: $7
Current: $7.46
Upside: -6.17%
May 7, 2026
Maintained: Hold
Price Target: $75
Current: $76.82
Upside: -2.37%
May 7, 2026
Maintained: Buy
Price Target: $58
Current: $47.67
Upside: +21.67%
May 7, 2026
Maintained: Buy
Price Target: $20
Current: $18.41
Upside: +8.64%
Apr 29, 2026
Maintained: Buy
Price Target: $50 → $60
Current: $62.84
Upside: -4.52%
Mar 11, 2026
Maintained: Buy
Price Target: $145 → $130
Current: $89.33
Upside: +45.53%
Jan 30, 2026
Maintained: Buy
Price Target: $50
Current: $19.26
Upside: +159.61%
Jan 30, 2026
Maintained: Buy
Price Target: $55
Current: $29.64
Upside: +85.56%
Jan 30, 2026
Maintained: Buy
Price Target: $4
Current: $2.13
Upside: +87.79%
Jun 10, 2024
Maintained: Hold
Price Target: $170
Current: $263.40
Upside: n/a
Jun 6, 2024
Maintained: Buy
Price Target: $22
Current: $1.49
Upside: n/a
Jun 4, 2024
Maintained: Buy
Price Target: $130
Current: $59.33
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: $17
Current: $1.57
Upside: n/a
May 23, 2024
Maintained: Buy
Price Target: $100
Current: $46.54
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $10 → $14
Current: $3.18
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $14 → $9
Current: $12.63
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $36
Current: $26.71
Upside: n/a
May 10, 2024
Maintained: Buy
Price Target: $101
Current: $54.66
Upside: n/a
Mar 15, 2024
Rated: Hold
Price Target: n/a
Current: $0.8509
Upside: n/a
Dec 15, 2023
Downgraded: Hold
Price Target: $23 → $15
Current: $30.63
Upside: n/a
Oct 11, 2023
Maintained: Sell
Price Target: n/a
Current: $51.35
Upside: n/a
Sep 29, 2023
Rated: Hold
Price Target: n/a
Current: $2.11
Upside: n/a
Sep 8, 2023
Downgraded: Hold
Price Target: $23 → $14
Current: $8.69
Upside: n/a
Jul 18, 2023
Reiterated: Buy
Price Target: $35 → $25
Current: $15.33
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $13
Current: $86.22
Upside: n/a
Mar 6, 2023
Reiterated: Buy
Price Target: $13 → $18
Current: $84.02
Upside: n/a
Feb 28, 2023
Reiterated: Hold
Price Target: $23
Current: $28.42
Upside: n/a
Feb 23, 2023
Downgraded: Sell
Price Target: $8 → $2
Current: $5.48
Upside: n/a
Feb 22, 2023
Reiterated: Sell
Price Target: $80 → $150
Current: $528.47
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: $15 → $16
Current: $2.60
Upside: n/a
Feb 17, 2023
Initiated Coverage: Hold
Price Target: $49
Current: $80.74
Upside: n/a
Feb 16, 2023
Reiterated: Sell
Price Target: $2 → $24
Current: $0.9701
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $83 → $44
Current: $0.8475
Upside: n/a
Jun 8, 2022
Downgraded: Hold
Price Target: $12 → $4
Current: $9.79
Upside: n/a
May 18, 2022
Reiterated: Buy
Price Target: $75 → $62
Current: $1.24
Upside: n/a
May 17, 2022
Maintained: Buy
Price Target: $28 → $20
Current: $19.11
Upside: n/a
Jan 13, 2022
Reiterated: Buy
Price Target: $60
Current: $9.73
Upside: n/a
Oct 8, 2021
Maintained: Hold
Price Target: $49 → $75
Current: $8.75
Upside: n/a
Jun 8, 2021
Upgraded: Hold
Price Target: n/a
Current: $0.82
Upside: n/a
Mar 19, 2021
Maintained: Buy
Price Target: $35
Current: $31.54
Upside: n/a
Jan 5, 2021
Maintained: Buy
Price Target: $70
Current: $3.19
Upside: n/a
Dec 7, 2020
Reiterated: Buy
Price Target: $9
Current: $9.34
Upside: n/a
Nov 23, 2020
Initiated Coverage: Buy
Price Target: $21
Current: $28.82
Upside: n/a
Sep 8, 2020
Initiated Coverage: Buy
Price Target: $20
Current: $0.065
Upside: n/a
Jun 25, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $15.15
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: $20 → $19
Current: $57.36
Upside: n/a
Feb 20, 2020
Maintained: Hold
Price Target: €79.11
Current: €139.15
Upside: n/a
Dec 3, 2019
Initiated Coverage: Buy
Price Target: $27 → $32
Current: $0.136
Upside: n/a
May 3, 2019
Downgraded: Hold
Price Target: $90 → $82
Current: $117.67
Upside: n/a
May 2, 2019
Maintained: Hold
Price Target: $13 → $13
Current: $3.71
Upside: n/a
Mar 29, 2019
Maintained: Hold
Price Target: $8
Current: $13.63
Upside: n/a
Mar 29, 2019
Maintained: Buy
Price Target: $27
Current: $1.48
Upside: n/a
Mar 28, 2019
Maintained: Buy
Price Target: $103 → $110
Current: $175.77
Upside: n/a
Mar 11, 2019
Initiated Coverage: Buy
Price Target: $16
Current: $3.24
Upside: n/a
Feb 20, 2019
Rated: Buy
Price Target: $43.71
Current: $6.25
Upside: n/a
Sep 7, 2017
Rated: Buy
Price Target: $80 → $105
Current: $271.77
Upside: n/a
Sep 7, 2017
Rated: Sell
Price Target: $20 → $8
Current: $22.86
Upside: n/a
Oct 23, 2015
Downgraded: Sell
Price Target: $25 → $16
Current: $12.78
Upside: n/a
Dec 2, 2014
Downgraded: Hold
Price Target: $60 → $90
Current: $36.36
Upside: n/a
Sep 17, 2012
Downgraded: Hold
Price Target: n/a
Current: $11.93
Upside: n/a